< Back to companies

Oncophenomics (previously Theranosis Life Sciences) is a personalized medicine startup addressing unmet needs in cancer diagnostics, prognostics and theranostics. We are developing microfluidics based lab-on-a-chip medical devices that can detect rare cells such as circulating tumor cells in a simple blood sample drawn from a cancer patient (also known as liquid biopsy) for monitoring the treatment efficacy, predict clinical outcomes and post treatment follow up (surveillance) for cancer recurrence in the form of secondary metastasis. Our patent pending advanced microfluidics chip is designed in such a way so as to capture specific populations of rare cells and perform downstream characterizations. It can be extended beyond cancer research, for example rare fetal cells in maternal blood circulation, circulating endothelial cells in atherosclerosis etc.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
oncophenomics.com/

Categories

CancerDiagnosticsMedical DevicesPrecision Medicine/Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Oncophenomics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now